Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
AstraZeneca is resuming clinical trials for the COVID-19 vaccine, ChAdOx1 nCoV-19, following confirmation that is safe to do so. The trials were paused when one of the participants developed an “unexplained illness”. The pause is…
Read More